PET ligands [11C]UCB-J (targeting synaptic glycoprotein 2A, a marker of pre-synaptic terminals) and [18F]BCPP-EF (targeting mitochondrial complex 1, a marker of mitochondrial density) are used to assess neuroplasticity changes at a cellular/molecular level.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (2)

• neuroplasticity concept
• PET concept